News

Carmot will continue to apply its proprietary lead-identification technology, Chemotype Evolution, to further advance molecules discovered during the initial collaboration. Amgen will be solely responsible for the clinical

The randomized, controlled, Phase 3 study (Protocol NCT01696084), conducted at 39 centers in the United States and Canada, compared VYXEOS to the conventional cytarabine and daunorubicin treatment regimen

Blood banks in the US have been urged to reject donations from people who have traveled to areas where the Zika virus is active or from those who

The endpoint was met at week 12 against placebo achieved p value of <0.0001. Zilretta also demonstrated significant analgesia against placebo at weeks 1 through 16. Flexion said

Mr. Chris Bainbridge, MB ChB, FRCSEd, the Co-Principal Investigator of the GRIP Study, performed the surgery at The Pulvertaft Hand Centre within the Royal Derby Hospital in Derby,

The biosimilar is manufactured by JHL’s Taiwanese subsidiary. It is the first company from the Greater China to secure European approval for clinical trial of a monoclonal antibody

Merck received a complete response letter from the agency. The company said it will review the letter and determine its next steps. The applications were based on the

The drug also improved erythroid response, an important measure of the formation of new red blood cells. The company said data from the phase 3 Arcade study was

Amounts, unless specified otherwise, are expressed in United States dollars and in accordance with International Financial Reporting Standards ("IFRS"). First Quarter Highlights and Corporate Update Enrollment of First